Tag Archives: implantable cardiac defibrillator (ICD)

Introduction The ways of risk stratification for sudden cardiac death (SCD) and the selection of patients for prophylactic implantable cardiac defibrillator (ICD) in hypertrophic cardiomyopathy (HCM) are still evolving and far from ideal. The following is a historical case (initial presentation was in 2019) of HCM that did not have recognised SCD risk factors. The calculated European Society of Cardiology (ESC) RISK-SCD score1 was a 1.88% chance of SCD in five years and, hence, an ICD was not recommended. The patient died suddenly, 18 months after the diagnosis was made. The ESC had modified guidelines for prophylactic ICD implantation in HCM